Search Orphan Drug Designations and Approvals
-
Generic Name: | flunarizine |
---|---|
Date Designated: | 11/20/2018 |
Orphan Designation: | Treatment of Alternating Hemiplegia |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Xenon Pharmaceuticals, Inc. 200-3650 Gilmore Way Burnaby, British Columbia V5G 4W8 Canada The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-